|
HEB-Hemispherx BioPharma, 谁是股东?
[复制链接]
|
|
发表于 26-5-2009 09:24 PM
|
显示全部楼层
Hemispherx Biopharma Press Release for
Tuesday, May 26, 2009
HEMISPHERX BIOPHARMA ANNOUNCES POSSIBLE BRIEF DELAY IN FDA ACTION ON AMPLIGEN® NEW DRUG APPLICATION
Philadelphia, PA, Tuesday, May 26, 2009: Hemispherx Biopharma, Inc. (NYSE/AMEX -HEB) today announced that the U.S. Food and Drug administration (“FDA”) has advised the company that it may require up to 1-2 additional weeks to take action beyond the scheduled Prescription Drug User Fee Act action date of May 25, 2009 on the New Drug Application for Ampligen® (Poly I Poly C12U), a selective TLR3 modulator, for the management of Chronic Fatigue Syndrome. Reason for the possible delay was attributed by the Agency to certain staff scheduling changes which might (or might not) delay the report. Accordingly the Company’s development plan for Ampligen® continues as described in the recently filed 10Q and 10K, as the FDA did not request additional information from the Company at this time. |
|
|
|
|
|
|
|
发表于 26-5-2009 09:25 PM
|
显示全部楼层
HEB我有3粒半。。。。
[ 本帖最后由 葉芬 于 26-5-2009 09:27 PM 编辑 ] |
|
|
|
|
|
|
|
发表于 26-5-2009 09:25 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 26-5-2009 09:28 PM
|
显示全部楼层
原帖由 葉芬 于 26-5-2009 09:24 PM 发表
Hemispherx Biopharma Press Release for
Tuesday, May 26, 2009
HEMISPHERX BIOPHARMA ANNOUNCES POSSIBLE BRIEF DELAY IN FDA ACTION ON AMPLIGEN® NEW DRUG APPLICATION
Philadelphia, PA, Tuesday ...
郁闷中
又要延迟了,唉~漫长的等待有来临了。。。 |
|
|
|
|
|
|
|
发表于 26-5-2009 09:37 PM
|
显示全部楼层
窩只有2粒罷了. |
|
|
|
|
|
|
|
发表于 26-5-2009 09:42 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 26-5-2009 09:43 PM
|
显示全部楼层
原帖由 m.i.k.e 于 26-5-2009 09:42 PM 发表
HEB 股东名单wobushi 200
napster 5000
miku 1000
blazechee 1000
cschiaw 5000
小锋 3000
mike 1000 (斩掉4000,减低风险)
叶芬 3500
Jochen 200
ng33 2000
sunny仔 (不要忙着和Kooileng交流,有HEB的 ...
其实我加码到3500了 |
|
|
|
|
|
|
|
发表于 26-5-2009 09:45 PM
|
显示全部楼层
很多人都认为,delay并不是一件坏的事,反之对approval更加有信心了. 普遍上大家都认为,如果不批准,干脆就直接讲不批准,不用浪费时间去搞什么paper work;反之,因为批准了,所以需要更多时间来处理paperwork....你又怎样想呢? |
|
|
|
|
|
|
|
发表于 26-5-2009 09:46 PM
|
显示全部楼层
其实我认为如果FDA 要reject 的话,早都reject了 。
延迟是好事来的。
我是contra 的。要出3000units.收上2000units. |
|
|
|
|
|
|
|
发表于 26-5-2009 09:49 PM
|
显示全部楼层
原帖由 小鋒 于 26-5-2009 09:45 PM 发表
很多人都认为,delay并不是一件坏的事,反之对approval更加有信心了. 普遍上大家都认为,如果不批准,干脆就直接讲不批准,不用浪费时间去搞什么paper work;反之,因为批准了,所以需要更多时间来处理paperwork....你又怎样 ...
我是担心会不会再来一次dilution. |
|
|
|
|
|
|
|
发表于 26-5-2009 09:59 PM
|
显示全部楼层
原帖由 napster 于 26-5-2009 09:51 PM 发表
不如你利用同样的方法,替大家弄个回酬率和盈利名单?谢谢
我不知道股东们肯透露买价吗? |
|
|
|
|
|
|
|
发表于 26-5-2009 10:03 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 26-5-2009 10:09 PM
|
显示全部楼层
原帖由 napster 于 26-5-2009 09:51 PM 发表
不如你利用同样的方法,替大家弄个回酬率和盈利名单?谢谢
这也要大家肯透露实价才行. |
|
|
|
|
|
|
|
发表于 26-5-2009 10:20 PM
|
显示全部楼层
分享一下http://online.wsj.com/article/SB124328188115551961.html
刚上任的FDA chief 需要清掉手上的股份, 这也是大家猜测delay的原因之一.
根据新闻报导,新chief的老公任职的hedge fund company是HEB十大持股公司之一.所以不难猜测为何要delay了,可能是因为股份还没完全脱手,所以要delay一下结果.当然啦,也可能是rejected的.
既然要担任政府高官,自然要与商界撇清关系...
[ 本帖最后由 小鋒 于 26-5-2009 10:52 PM 编辑 ] |
|
|
|
|
|
|
|
发表于 26-5-2009 10:22 PM
|
显示全部楼层
m.i.k.e.
請幫忙放多一人名 Liew,他目前手上有3粒。
(本來有5粒,上星期五出了2粒,剩下3粒)
TQ
[ 本帖最后由 葉芬 于 26-5-2009 10:35 PM 编辑 ] |
|
|
|
|
|
|
|
发表于 26-5-2009 10:24 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 26-5-2009 10:31 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 26-5-2009 10:35 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 26-5-2009 10:50 PM
|
显示全部楼层
http://www.sbwire.com/news/view/28054
BioMedReports: Small Biotech Firms (Amex: HEB)(Nasdaq: NVAX) Could Reap Benefits From Government's Flu Vaccine Initiative
Posted on Tuesday, May 26, 2009
Biomedical news portal takes a closer look at companies that could benefit from the U.S. government's billion dollar vaccine initiative.
Los Angeles, CA -- (SBWIRE) -- 05/26/2009 -- BioMedReports, the news portal covering the biomedical news and financial sector takes a special look at which biotech firms could reap benefits from the just announced U.S. government's billion dollar initiative for the commercial-scale production of two potential vaccine ingredients for the pre-pandemic novel Influenza A(H1N1) stockpile.
The special report presents a comprehensive overview of influenza drugs and other antiviral agents that have made it to testing in humans and it also focuses on two companies who are taking advantage of this situation to showcase their technology: Philadelphia-based Hemispherx Biopharma Inc. (Amex: HEB) and Rockville, Md.-based Novavax Inc. (Nasdaq: NVAX).
The full report appears at BiomedReports.com.
http://biomedreports.com/article ... fluenza-a-h1n1.html
Biotech investors interested in seeing the complete database of clinical trials and upcoming FDA decisions can access that information here:
http://biomedreports.com/component/content/article/548.html |
|
|
|
|
|
|
|
发表于 26-5-2009 10:53 PM
|
显示全部楼层
原帖由 葉芬 于 26-5-2009 10:22 PM 发表
m.i.k.e.
請幫忙放多一人名 Liew,他目前手上有3粒。
(本來有5粒,上星期五出了2粒,剩下3粒)
TQ
HEB 股东名单
wobushi 200
napster 5000
miku 1000
blazechee 1000
cschiaw 5000
小锋 3500
mike 1000
叶芬 3500
Jochen 200
ng33 2000
Liew 3000
sunny仔 (不要忙着和Kooileng交流,有HEB的话,请报数一下.)
Orochimaru ???
如果有漏掉或不对的,请通知.
(我好像太空闲了,帮大家做记录. )
如果还有新股东报到,我明天再update.
今晚的HEB会起,应该是shorter在cover回.
不看了,我要出去透透气.
希望大家今晚又有$进袋. |
|
|
|
|
|
|
| |
本周最热论坛帖子
|